

Pharma-biotech industry professional equally experienced in Operations and R&D, across multiple areas (Regulatory Affairs & LCM, R&D Project Management, Sales, Quality Control) in top-tier innovative and generics companies.
Highly skilled at working in global matrix organizations fostering stakeholder value creation and at positively impacting the triple bottom line.
Holds an MBA from WBS with a dissertation focused on Strategy & International Business critically analysing how political environment impacts performance and sustained competitive advantages of top 10 pharma companies by market cap. Can employ a broad array of frameworks and principles of commerce in global economies to deliver practical solutions to current pharma business challenges.
Led cross-functional and cross-cultural teams in a global matrix environment, delivering R&D projects with a total NPV of over$100M, surpassing yearly KPIs by 30%.
• Led tri-weekly update calls with C-suite stakeholders and tracked R&D project progress using PLM Planisware. These updates directly influenced budget allocation, project prioritization, and cancellation decisions.
• Facilitated project kick-off meetings to align cross-functional teams on investment goals, budget expectations, and strategic outcomes.
• Performed variable cost analysis and contributed to Annual Operating Plans (AOP) and Long-Range Plans (LRP).
• Drafted Capital Expense Requests (CERs) up to $1M USD for C-suite approval, including financial justification and scenarios to support strategic investments.
Pharmaceutical Industry
Bio-tech
AI
GLP-1
Neuralink
Business
Finance
Health Legal Landscape